Crossmark

iPCSK9 treatment of familial hypercholesterolemia in a patient diagnosed as congenital muscular dystrophy with contraindication for statin use

Crossref DOI link: https://doi.org/10.1016/j.artere.2019.11.001

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Arnedo Hernández, Sergio

Mosquera Lozano, José Daniel

Martínez de Narvajas Urra, Iratxe

Menéndez Fernández, Estela

Rabadán Pejenaute, Elisa

Baeza Trinidad, Ramón

Casañas Martínez, Marta

Brea Hernando, Angel
License Information

Text and Data Mining valid from 2019-11-01
More Information

This article is maintained by: Elsevier

Article Title: iPCSK9 treatment of familial hypercholesterolemia in a patient diagnosed as congenital muscular dystrophy with contraindication for statin use

Journal Title: Clínica e Investigación en Arteriosclerosis (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.artere.2019.11.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arteri.2019.01.005

Content Type: article

Copyright: © 2019 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.